![Delivery Challenges from the Oncology Pipeline](https://d38uvx7mib76ry.cloudfront.net/public/images/KtKZ8eWZDTc3KHctMQwakc58erXkmiezGIWodFIR.png)
Summary:
This podcast features a panel discussion from the 2023 PODD: Partnership Opportunities in Drug Delivery Conference on delivery challenges from the oncology pipeline including intramodality competition between monoclonal antibodies, bispecifics, ADCs, CARs and other cell therapies; negotiating the tradeoffs between therapeutic efficacy, regimen simplicity, and technical complexity; and impacts of different modalities on stakeholders from manufacturing to HCPs and patients.
To learn more about the PODD conference, please visit PODDConference.com.
Related Podcasts
View All![Unlocking ctDNA's Potential for Prognostic Stratification, Tumor Evolution Insights & Accelerated Drug Development](https://d38uvx7mib76ry.cloudfront.net/public/images/B1auwoT8ay8rv3yuV4VCj1STzbGoy021dONMzRpa.png)
Unlocking ctDNA's Potential for Prognostic Stratification, Tumor Evolution Insights & Accelerated Drug Development
![Key Lessons from Manufacturing Cell-Based Immunotherapies to Accelerate Development and Process](https://d38uvx7mib76ry.cloudfront.net/public/images/AYpBueo73sCdV35PWH03VZAbzSTl5LAzpocI3Dw2.png)
Key Lessons from Manufacturing Cell-Based Immunotherapies to Accelerate Development and Process
![Targeting TGF Beta in IO: Mechanisms, Challenges and Opportunities](https://d38uvx7mib76ry.cloudfront.net/public/images/7vsSLL3HBWLTBtdS3MMK2xSWLQbAiFFpcrzUwzxk.png)
Targeting TGF Beta in IO: Mechanisms, Challenges and Opportunities
![Delivery Challenges from the Oncology Pipeline](https://d38uvx7mib76ry.cloudfront.net/public/images/KtKZ8eWZDTc3KHctMQwakc58erXkmiezGIWodFIR.png)